Name: Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the
Uploaded: 2026-10-05T20:15:00+00:00
Description: Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of Concurrent explains

Reuters Business@ReutersBiz

2026.10.05 20:15

Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of Concurrent explains

显示更多